$BTM
Bitcoin Depot Inc.

2022 Q2 Form 10-Q Financial Statement

#000119312522221196 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $0.00 $0.00 $152.0M
YoY Change
Cost Of Revenue $149.2M $138.0M $129.8M
YoY Change
Gross Profit $18.70M $16.50M $22.20M
YoY Change
Gross Profit Margin 14.61%
Selling, General & Admin $527.7K $212.5K $10.90M
YoY Change
% of Gross Profit 2.82% 1.29% 49.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.400M $4.800M $4.610M
YoY Change -3.72%
% of Gross Profit 23.53% 29.09% 20.77%
Operating Expenses $527.7K $212.5K $15.60M
YoY Change
Operating Profit -$527.7K -$212.5K -$10.97K
YoY Change
Interest Expense $409.0K -$226.8K -$2.900M
YoY Change
% of Operating Profit
Other Income/Expense, Net $409.0K -$226.8K $0.00
YoY Change
Pretax Income -$118.8K -$439.2K -$10.97K
YoY Change
Income Tax $17.11K $0.00 $0.00
% Of Pretax Income
Net Earnings -$135.9K -$439.2K -$10.97K
YoY Change
Net Earnings / Revenue -0.01%
Basic Earnings Per Share
Diluted Earnings Per Share -$3.438K -$11.11K -$0.31
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.523M $1.759M
YoY Change
Cash & Equivalents $1.500M $1.759M $44.74K
Short-Term Investments
Other Short-Term Assets $776.2K $923.0K
YoY Change
Inventory
Prepaid Expenses $776.2K
Receivables
Other Receivables
Total Short-Term Assets $2.299M $2.682M $44.74K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $37.81M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $321.2M $320.8M
YoY Change
Other Assets $20.00K
YoY Change
Total Long-Term Assets $321.2M $320.8M $350.2K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.299M $2.682M $44.74K
Total Long-Term Assets $321.2M $320.8M $350.2K
Total Assets $323.5M $323.4M $394.9K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $53.95K $8.220K
YoY Change
Accrued Expenses $119.2K $120.1K $300.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $20.40M
YoY Change
Total Short-Term Liabilities $290.3K $128.3K $380.9K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.680M
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $290.3K $128.3K $380.9K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $290.3K $128.3K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$586.1K -$10.97K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.191M $2.327M $14.04K
YoY Change
Total Liabilities & Shareholders Equity $323.5M $323.4M $394.9K
YoY Change

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$135.9K -$439.2K -$10.97K
YoY Change
Depreciation, Depletion And Amortization $4.400M $4.800M $4.610M
YoY Change -3.72%
Cash From Operating Activities -$236.0K -$1.088M -$60.00
YoY Change -116.39%
INVESTING ACTIVITIES
Capital Expenditures $330.0K $370.0K $2.750M
YoY Change -86.02%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$321.0M $0.00
YoY Change
Cash From Investing Activities $0.00 -$321.0M $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 323.8M 44.80K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -236.0K -1.088M -60.00
Cash From Investing Activities 0.000 -321.0M 0.000
Cash From Financing Activities 0.000 323.8M 44.80K
Net Change In Cash -236.0K 1.715M 44.74K
YoY Change -85.7%
FREE CASH FLOW
Cash From Operating Activities -$236.0K -$1.088M -$60.00
Capital Expenditures $330.0K $370.0K $2.750M
Free Cash Flow -$566.0K -$1.458M -$2.750M
YoY Change -38.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001901799
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
GSR II Meteora Acquisition Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-41305
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3203989
dei Entity Address Address Line1
EntityAddressAddressLine1
840 Park Drive East
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33432
dei City Area Code
CityAreaCode
561
dei Local Phone Number
LocalPhoneNumber
532-4682
dei Security12b Title
Security12bTitle
Class A common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
GSRM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 us-gaap Cash
Cash
1523280
CY2021Q4 us-gaap Cash
Cash
44739
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
776178
CY2022Q2 us-gaap Assets Current
AssetsCurrent
2299458
CY2021Q4 us-gaap Assets Current
AssetsCurrent
44739
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
350201
CY2022Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
321175953
CY2022Q2 us-gaap Assets
Assets
323475411
CY2021Q4 us-gaap Assets
Assets
394940
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
53945
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119171
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
300000
CY2022Q2 gsrm Franchise Tax Payable
FranchiseTaxPayable
100050
CY2021Q4 gsrm Franchise Tax Payable
FranchiseTaxPayable
905
CY2022Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
17112
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
80000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
290278
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
380905
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
320993750
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
323475411
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
394940
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
477741
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
39171
gsrm Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
99145
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
17112
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1324108
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2776657
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24209
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-586065
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10965
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2191383
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14035
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
640378
CY2022Q2 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
50000
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
99813
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-527741
us-gaap Operating Income Loss
OperatingIncomeLoss
-740191
CY2022Q2 gsrm Change In Value Of Investments Held In Trust Account
ChangeInValueOfInvestmentsHeldInTrustAccount
-408963
gsrm Change In Value Of Investments Held In Trust Account
ChangeInValueOfInvestmentsHeldInTrustAccount
-182203
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
408963
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
182203
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-118778
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-557988
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17112
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17112
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-135890
us-gaap Net Income Loss
NetIncomeLoss
-575100
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14035
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
12223750
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
17710000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
135698
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
27045604
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-439210
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2327273
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-135890
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2191383
us-gaap Net Income Loss
NetIncomeLoss
-575100
gsrm Change In Value Of Investments Held In Trust Account
ChangeInValueOfInvestmentsHeldInTrustAccount
-182203
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
776178
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
53945
gsrm Threshold Percentage Of Public Shares Subject To Redemption Without Company Prior Written Consent
ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent
0.15
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-320993750
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
320993750
gsrm Percentage Of Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageOfObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
1
gsrm Months To Complete Acquisition
MonthsToCompleteAcquisition
P15M
gsrm Maximum Period To Complete Acquisitions
MaximumPeriodToCompleteAcquisitions
P17M
gsrm Dissolution Expenses
DissolutionExpenses
100000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1500000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
161543
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
241543
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
316250000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
12223750
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4597351
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
323796399
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1478541
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44739
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1523280
gsrm Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
70000
gsrm Reversal Of Accrued Offering Costs
ReversalOfAccruedOfferingCosts
290000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-10-14
gsrm Threshold Minimum Aggregate Fair Market Value As Percentage Of Net Assets Held In Trust Account
ThresholdMinimumAggregateFairMarketValueAsPercentageOfNetAssetsHeldInTrustAccount
0.80
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
5000001
CY2022Q2 gsrm Working Capital
WorkingCapital
2000000
CY2022Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
117000
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of income and expenses during the reporting period. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of June 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div>
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
gsrm Restricted Investments Term
RestrictedInvestmentsTerm
P185D
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1976562
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-135890
us-gaap Net Income Loss
NetIncomeLoss
-575100
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-27045604
CY2022Q2 gsrm Net Income Loss Including Accretion Of Temporary Equity To Redemption Value
NetIncomeLossIncludingAccretionOfTemporaryEquityToRedemptionValue
-135890
gsrm Net Income Loss Including Accretion Of Temporary Equity To Redemption Value
NetIncomeLossIncludingAccretionOfTemporaryEquityToRedemptionValue
-27620704
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 gsrm Percentage Of Total Number Of Shares Issued In The Initial Public Offering
PercentageOfTotalNumberOfSharesIssuedInTheInitialPublicOffering
0.20
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1976562
CY2022Q2 us-gaap Shares Issued
SharesIssued
0
CY2021Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0
CY2022Q2 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
199998
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
266664
CY2022Q1 gsrm Per Unit Amount Of Marketing Fees May Be Paid At Sole Discretion Of Entity To Third Party Advisors Not Participated In Ipo That Assist In Consummate Business Combination
PerUnitAmountOfMarketingFeesMayBePaidAtSoleDiscretionOfEntityToThirdPartyAdvisorsNotParticipatedInIpoThatAssistInConsummateBusinessCombination
0.00105
CY2022Q1 gsrm Value Of Marketing Fees May Be Paid At Sole Discretion Of Entity To Third Party Advisors Not Participated In Ipo That Assist In Consummate Business Combination
ValueOfMarketingFeesMayBePaidAtSoleDiscretionOfEntityToThirdPartyAdvisorsNotParticipatedInIpoThatAssistInConsummateBusinessCombination
3300000

Files In Submission

Name View Source Status
0001193125-22-221196-index-headers.html Edgar Link pending
0001193125-22-221196-index.html Edgar Link pending
0001193125-22-221196.txt Edgar Link pending
0001193125-22-221196-xbrl.zip Edgar Link pending
d307635d10q.htm Edgar Link pending
d307635dex311.htm Edgar Link pending
d307635dex312.htm Edgar Link pending
d307635dex321.htm Edgar Link pending
d307635dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gsrm-20220630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gsrm-20220630_cal.xml Edgar Link unprocessable
gsrm-20220630_def.xml Edgar Link unprocessable
gsrm-20220630_lab.xml Edgar Link unprocessable
gsrm-20220630_pre.xml Edgar Link unprocessable
d307635d10q_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending